These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 9779383

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Microbiological profile of telithromycin, the first ketolide antimicrobial.
    Felmingham D.
    Clin Microbiol Infect; 2001; 7 Suppl 3():2-10. PubMed ID: 11523558
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Grepafloxacin--a new fluoroquinolone.
    Med Lett Drugs Ther; 1998 Jan 30; 40(1019):17-8. PubMed ID: 9465856
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of in-vitro activity of new quinolones, macrolides, and minocycline against Mycoplasma pneumoniae.
    Sato K.
    J Infect Chemother; 2000 Sep 30; 6(3):188. PubMed ID: 11810563
    [No Abstract] [Full Text] [Related]

  • 8. In vitro activities of macrolides against gram-positive aerobes, Haemophilus influenzae, Moraxella catarrhalis and Bacteroides fragilis in Taiwan.
    Wang FD, Liu IM, Liu CY.
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Apr 30; 62(4):230-5. PubMed ID: 10367484
    [Abstract] [Full Text] [Related]

  • 9. [Antimicrobial drug therapy and microbial sensitivity tests: general concept of antibiotics].
    Miyazakin S, Yamaguchi K.
    Rinsho Byori; 1997 Jul 30; Suppl 105():162-73. PubMed ID: 9379536
    [No Abstract] [Full Text] [Related]

  • 10. The in-vitro activity of OPC-17116, a new 5-methyl substituted quinolone.
    Wise R, Andrews JM, Brenwald N.
    J Antimicrob Chemother; 1993 Apr 30; 31(4):497-504. PubMed ID: 8390433
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of in-vitro activity of new quinolones, macrolides, and minocycline against Mycoplasma pneumoniae.
    Ikejima H, Yamamoto H, Ishida K, Kaku M, Shimada J.
    J Infect Chemother; 2000 Sep 30; 6(3):148-50. PubMed ID: 11810555
    [Abstract] [Full Text] [Related]

  • 12. Susceptibility of ninety-eight clinical isolates of Legionella to macrolides and quinolones using the Etest.
    Schrock J, Hackman BA, Plouffe JF.
    Diagn Microbiol Infect Dis; 1997 Aug 30; 28(4):221-3. PubMed ID: 9327252
    [Abstract] [Full Text] [Related]

  • 13. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
    Renaudin H, Bébéar C.
    Eur J Clin Microbiol Infect Dis; 1990 Nov 30; 9(11):838-41. PubMed ID: 1964899
    [Abstract] [Full Text] [Related]

  • 14. Antimicrobial symposium. Part IV. Cephalosporins.
    Cooper TW, Gibbs WJ, Bronze MS, Greenfield RA.
    J Okla State Med Assoc; 2006 Dec 30; 99(12):579-83. PubMed ID: 17310925
    [No Abstract] [Full Text] [Related]

  • 15. Antibiotic resistance of microorganisms involved in ear, nose and throat infections.
    Baquero F, Loza E.
    Pediatr Infect Dis J; 1994 Jan 30; 13(1 Suppl 1):S9-14; discussion S20-2. PubMed ID: 8159522
    [No Abstract] [Full Text] [Related]

  • 16. Quinolones and macrolides: roles in respiratory infections.
    Khan FA.
    Hosp Pract (Off Ed); 1993 Jan 15; 28(1):149-153, 156-62. PubMed ID: 8380424
    [Abstract] [Full Text] [Related]

  • 17. Comparative antimicrobial activity of ABT-773, a novel ketolide, tested against drug-resistant Gram-positive cocci and Haemophilus influenzae.
    Rospide MF, Biedenbach DJ, Jones RN.
    Int J Antimicrob Agents; 2001 Jun 15; 17(6):451-5. PubMed ID: 11397614
    [Abstract] [Full Text] [Related]

  • 18. DNA gyrase as a drug target.
    Maxwell A.
    Biochem Soc Trans; 1999 Feb 15; 27(2):48-53. PubMed ID: 10093705
    [No Abstract] [Full Text] [Related]

  • 19. [A consideration on the results of nationwide surveillance of antimicrobial susceptibilities--gram-positive cocci and gram-negative cocci].
    Kuroyama M, Okamoto E, Yago K.
    Jpn J Antibiot; 1998 Dec 15; 51(12):764-78. PubMed ID: 10077775
    [Abstract] [Full Text] [Related]

  • 20. Susceptibility of European respiratory tract isolates to trovafloxacin, ciprofloxacin, clarithromycin, azithromycin and ampicillin.
    Pontani D, Washton H, Bouchillon S, Johnson J.
    Eur J Clin Microbiol Infect Dis; 1998 Jun 15; 17(6):413-9. PubMed ID: 9758284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.